Lymphocyte proliferative response to Helicobacter pylori antigens in H. pylori-infected patients.
Helicobacter pylori (Hp) contributes to the development of gastric and extra-gastric diseases such as autoimmune thyroiditis (AT), and causes persistent life-long infection despite local and systemic immune response. We determined the specific cellular immune response to Hp antigens and PWM (control mitogen) in two groups of Hp infected patients--group A (n = 21), involving patients with autoimmune thyroiditis and group B (n = 13) of patients without AT--using modified lymphocyte transformation test before and after eradication therapy in comparison with healthy controls (group C, n = 15). Immune reactivity to the majority of Hp antigens (aHp, hHp, HpAg, CagA) was significantly lower in group B before eradication therapy in comparison with healthy Hp negative controls. A significant increase in immune reactivity was observed in group B to certain Hp antigens after successful eradication. The same levels (but insignificant) of immune reactivity were shown in group A. Our results indicate that Hp can cause the inhibition of the specific cellular immune response in Hp infected patients with or without autoimmune diseases such as AT, which can be abrogated by successful eradication of Hp. Lymphocyte transformation test appears to be a good tool for detection of immune memory cellular response in patients with Hp infection.
Institute of Immunology and Microbiology, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. hybenova@yahoo.com
M
M
Hybenova
P
P
Hrda
B
B
Potuznikova
E
E
Pavlik
V
V
Stejskal
J
J
Dosedel
I
I
Sterzl
D000328:Adult; D000942:Antigens, Bacterial / Q000276:immunology; D049109:Cell Proliferation; D005260:Female; D016481:Helicobacter Infections / Q000150:complications / Q000276:immunology*; D016480:Helicobacter pylori / Q000276:immunology*; D006801:Humans; D007108:Immune Tolerance; D008214:Lymphocytes / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D013967:Thyroiditis, Autoimmune / Q000150:complications / Q000276:immunology
D000942:Antigens, Bacterial
Clin Sci (Lond). 2006 Mar;110(3):305-14
16464172
Neuro Endocrinol Lett. 2004 Jun;25(3):211-8
15349088
Med Microbiol Immunol. 2010 May;199(2):109-16
20157729
J Clin Immunol. 1996 Jan;16(1):31-40
8926283
J Exp Med. 1998 Jan 5;187(1):135-40
9419220
J Clin Gastroenterol. 2007 Jul;41(6):548-58
17577110
J Infect Dis. 2004 May 15;189(10):1914-20
15122529
Med Microbiol Immunol. 1993 May;182(2):63-76
8332102
Gut. 2005 Jan;54(1):25-32
15591500
J Physiol Pharmacol. 1996 Mar;47(1):195-202
8777299
Helicobacter. 2006 Oct;11 Suppl 1:46-51
16925612
J Clin Gastroenterol. 1998 Jun;26(4):259-63
9649006
Rev Physiol Biochem Pharmacol. 2004;152:205-20
15549607
Clin Exp Immunol. 1991 Mar;83(3):396-400
1900743
Gut. 1997 Mar;40(3):297-301
9135515
Neuro Endocrinol Lett. 2003 Feb-Apr;24(1-2):57-64
12743534
Microsc Res Tech. 2001 Jun 15;53(6):419-24
11525260
Proc Natl Acad Sci U S A. 2004 May 18;101(20):7727-32
15128946
Helicobacter. 2008 Feb;13(1):1-19
18205661
Southeast Asian J Trop Med Public Health. 2001 Mar;32(1):88-94
11485102
Diagn Microbiol Infect Dis. 2007 Jan;57(1):27-34
16876371
Acta Gastroenterol Belg. 2000 Oct-Dec;63(4):388-92
11233523
J Gastroenterol. 2009;44(4):239-48
19271114
Immunol Lett. 2004 May 15;93(2-3):97-108
15158604
Infect Immun. 2005 Jan;73(1):523-31
15618192
J Exp Med. 2003 Dec 15;198(12):1887-97
14676300
Neuro Endocrinol Lett. 2006 Dec;27 Suppl 1:25-30
16804512
Best Pract Res Clin Gastroenterol. 2007;21(2):237-59
17382275
Presse Med. 1967 Feb 25;75(10):461-5
6017970
Endocr Rev. 1993 Feb;14(1):107-20
8491150
Clin Endocrinol (Oxf). 2004 Nov;61(5):650-2
15521972
J Infect. 2007 Mar;54(3):257-61
16824607
Gut. 1994 Oct;35(10):1379-84
7959191
J Immunol. 2006 Mar 1;176(5):3000-9
16493058
Helicobacter. 2006 Feb;11(1):21-30
16423086
Helicobacter. 2008 Aug;13(4):295-303
18665940
Zentralbl Bakteriol. 1993 Sep;280(1-2):166-76
8280939
Folia Microbiol (Praha). 2007;52(1):91-4
17571803
Dig Liver Dis. 2008 Aug;40(8):619-26
18396114
J Clin Invest. 2004 Feb;113(3):321-33
14755326
J Physiol Pharmacol. 1999 Dec;50(5):817-26
10695561